Together with our team members across Europe, the U.S., and Japan, we deliver development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells therapies. Evaluates emerging state and federal regulatory requirements and develops and implements EHS programs, policies, and procedures to ensure ongoing compliance, control site-specific risks, and support AGC Biologics requirements and global EHS goals.